Novozymes and Chr. Hansen have successfully merged, giving rise to Novonesis, a global biosolutions leader. With expertise spanning over 30 industries, Novonesis, comprising 10,000 professionals, is dedicated to enhancing business, promoting healthier lives and fostering a sustainable planet. Already aiding global companies, Novonesis stands as a formidable force in addressing both business and environmental challenges.
Novozymes and Chr. Hansen partnering
The merger will create Novonesis, a global biosolutions leader.
February 2, 2024
